Neoadjuvant chemoradiation and surgery improves survival outcomes compared with definitive chemoradiation in the treatment of stage IIIA N2 non-small-cell lung cancer-Reference-Cited by-同舟云学术

Neoadjuvant chemoradiation and surgery improves survival outcomes compared with definitive chemoradiation in the treatment of stage IIIA N2 non-small-cell lung cancer

Published:2015-01-06 Issue:5 Volume:48 Page:684-690
ISSN:1010-7940
Container-title:European Journal of Cardio-Thoracic Surgery
language:en
Short-container-title:Eur J Cardiothorac Surg

Author:

Darling Gail E.,Li Fei,Patsios Demetris,Massey Christine,Wallis Adam G.,Coate Linda,Keshavjee Shaf,Pierre Andrew,De Perrot Marc,Yasufuku Kazuhiro,Cypel Marcelo,Waddell Tom

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery

Link

http://academic.oup.com/ejcts/article-pdf/48/5/684/8066685/ezu504.pdf

Reference17 articles.

1. Stage IIIA-N2 NSCLC: A review of its treatment approaches and future developments

2. Albain KS Rusch VW Crowley JJ Rice TW Turrisi AT III Weick JK Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995;13:1880–92.

3. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival

4. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival☆

5. Treatment of Non-small Cell Lung Cancer-Stage IIIA

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. En bloc chest wall resection in locally advanced cT3N2 (stage IIIB) lung cancer involving the chest wall: Revisiting guidelines;JTCVS Open;2023-12

2. The prognostic value of tumor-infiltrating lymphocytes in non-small cell lung cancer patients who received neoadjuvant chemotherapy followed by surgery;Advances in Clinical and Experimental Medicine;2023-03-07

3. Case Report: Aumolertinib as Neoadjuvant Therapy for Patients With Unresectable Stage III Non-Small Cell Lung Cancer With Activated EGFR Mutation: Case Series;Frontiers in Oncology;2022-03-29

4. Lobectomy Versus Sublobectomy in Stage IIIA/N2 Non-Small Cell Lung Cancer: A Population-Based Study;Frontiers in Oncology;2021-12-09

5. Predictive Risk Factors for Early Recurrence of Stage pIIIA-N2 Non-Small Cell Lung Cancer;Cancer Management and Research;2021-11